Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells

A class of drugs successfully used for treatment of metabolic bone diseases is the nitrogen-containing bisphosphonates (N-BPs), which act by inhibiting the vital enzyme, farnesyl pyrophosphate synthase (FPPS), of the mevalonate pathway. Inhibition of FPPS by N-BPs results in the intracellular accumu...

ver descrição completa

Detalhes bibliográficos
Main Authors: Räikkönen, J, Taskinen, M, Dunford, J, Mönkkönen, H, Auriola, S, Mönkkönen, J
Formato: Journal article
Idioma:English
Publicado em: 2011